2dd8

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:2dd8.gif|left|200px]]
[[Image:2dd8.gif|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 2dd8 |SIZE=350|CAPTION= <scene name='initialview01'>2dd8</scene>, resolution 2.30&Aring;
+
The line below this paragraph, containing "STRUCTURE_2dd8", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY=
+
or leave the SCENE parameter empty for the default display.
-
|GENE= recombinant antibody Fab ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]), Tor2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id= Human SARS coronavirus])
+
-->
-
|DOMAIN=
+
{{STRUCTURE_2dd8| PDB=2dd8 | SCENE= }}
-
|RELATEDENTRY=[[2ajf|2AJF]], [[1za6|1ZA6]], [[2g75|2G75]]
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2dd8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2dd8 OCA], [http://www.ebi.ac.uk/pdbsum/2dd8 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2dd8 RCSB]</span>
+
-
}}
+
'''Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody'''
'''Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody'''
Line 33: Line 30:
[[Category: Xiao, X D.]]
[[Category: Xiao, X D.]]
[[Category: Zhu, Z Y.]]
[[Category: Zhu, Z Y.]]
-
[[Category: antibody]]
+
[[Category: Antibody]]
-
[[Category: crystal structure]]
+
[[Category: Crystal structure]]
-
[[Category: epitope]]
+
[[Category: Epitope]]
-
[[Category: inhibitor]]
+
[[Category: Inhibitor]]
-
[[Category: s protein]]
+
[[Category: S protein]]
-
[[Category: sar]]
+
[[Category: Sar]]
-
[[Category: vaccine]]
+
[[Category: Vaccine]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 00:12:29 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 02:33:07 2008''
+

Revision as of 21:12, 3 May 2008

Template:STRUCTURE 2dd8

Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody


Overview

The severe acute respiratory syndrome coronavirus (SARS-CoV, or SCV), which caused a world-wide epidemic in 2002 and 2003, binds to a receptor, angiotensin-converting enzyme 2 (ACE2), through the receptor-binding domain (RBD) of its envelope (spike, S) glycoprotein. The RBD is very immunogenic; it is a major SCV neutralization determinant and can elicit potent neutralizing antibodies capable of out-competing ACE2. However, the structural basis of RBD immunogenicity, RBD-mediated neutralization, and the role of RBD in entry steps following its binding to ACE2 have not been elucidated. By mimicking immune responses with the use of RBD as an antigen to screen a large human antibody library derived from healthy volunteers, we identified a novel potent cross-reactive SCV-neutralizing monoclonal antibody, m396, which competes with ACE2 for binding to RBD, and determined the crystal structure of the RBD-antibody complex at 2.3-A resolution. The antibody-bound RBD structure is completely defined, revealing two previously unresolved segments (residues 376-381 and 503-512) and a new disulfide bond (between residues 378 and 511). Interestingly, the overall structure of the m396-bound RBD is not significantly different from that of the ACE2-bound RBD. The antibody epitope is dominated by a 10-residue-long protruding beta6-beta7 loop with two putative ACE2-binding hotspot residues (Ile-489 and Tyr-491). These results provide a structural rationale for the function of a major determinant of SCV immunogenicity and neutralization, the development of SCV therapeutics based on the antibody paratope and epitope, and a retrovaccinology approach for the design of anti-SCV vaccines. The available structural information indicates that the SCV entry may not be mediated by ACE2-induced conformational changes in the RBD but may involve other conformational changes or/and yet to be identified coreceptors.

About this Structure

2DD8 is a Protein complex structure of sequences from Homo sapiens and Human sars coronavirus. Full crystallographic information is available from OCA.

Reference

Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody., Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, Xiao X, Ji X, Dimitrov DS, J Biol Chem. 2006 Jun 9;281(23):15829-36. Epub 2006 Apr 5. PMID:16597622 Page seeded by OCA on Sun May 4 00:12:29 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools